
Emit Imaging builds Cryo-Fluorescence Tomography systems and provides CFT fee-for-service research for preclinical imaging.
Emit Imaging was founded with the core mission of revolutionizing molecular tissue imaging and digital histology. The company focuses on developing and providing advanced cryo-fluorescence imaging technology, which enables high-resolution, high-sensitivity 3D imaging of tissues. Their flagship product, Xerra™, is a preclinical imaging tool designed to monitor drug pharmacokinetics and pharmacodynamics (PK/PD) and protein expression in whole animals. Emit Imaging primarily serves the biological and drug research markets, offering both instrumentation and imaging services.
Notable figures associated with Emit Imaging include leading experts in molecular imaging and digital histology. The company has attracted significant interest from investors focused on cutting-edge biomedical technologies. Key achievements include the successful development and commercialization of the Xerra™ platform, which has been widely adopted in preclinical research settings. Emit Imaging's impact is evident in its contribution to advancing drug discovery and biological research through innovative imaging solutions.
Emit Imaging's most recent funding round was for $7.1M (USD) in September 2024.
As of Sep 19, 2024, Emit Imaging has disclosed funding of $13.5M (USD).

Numira Biosciences
numirabio.com

X Sight
xsightinc.com

Real Time Tomography

Expansion Technologies
extbio.com

Quantificare
quantificare.com

CytoTronics
cytotronics.com

CytoViva
cytoviva.com

Health Technology Innovations
hti.ai

ClearLight Biotechnologies

Magnify Biosciences
magnifybiosci.com
Kereos

ABT Molecular Imaging

Imaginab
imaginab.com
Advanced fPAT Imaging

SynchroPET
synchropet.com

Tomophase
tomophase.com

Vergent Bioscience
vergentbio.com

Emit

Polarean
polarean.com

Imago Systems
imagosystems.com